Your browser version may not work well with NCBI's Web applications. More information here...
1: Clin Liver Dis. 2007 Aug;11(3):477-505, v.Click here to read Links

Causality assessment of drug-induced hepatotoxicity: promises and pitfalls.

Hepatology Section, Division of Gastroenterology, Georgetown University Hospital, Georgetown University Medical Center, Washington, DC 20007, USA.

Drug-induced liver injury is the leading cause of acute liver failure in the United States, but the ability to ascribe hepatic injury confidently to a specific drug remains a challenging and often difficult pursuit. This article explores the ongoing challenges inherent in what is currently a clinical process of elimination made in the attempt of assigning causality in drug-induced liver injury. In particular, it points out the shortcomings and pitfalls that often limit the applicability of the causality-assessment methodologies currently in use.

PMID: 17723916 [PubMed - indexed for MEDLINE]